{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "05/06/2026",
      "update_type": "New",
      "initial_posting_date": "05/06/2026",
      "package_ndc": "0409-1103-01",
      "generic_name": "Cisatracurium Besylate Injection",
      "contact_info": "844-646-4398",
      "related_info": "Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "ANDA203236"
        ],
        "brand_name": [
          "CISATRACURIUM BESYLATE"
        ],
        "generic_name": [
          "CISATRACURIUM BESYLATE"
        ],
        "manufacturer_name": [
          "Hospira, Inc."
        ],
        "product_ndc": [
          "0409-1103",
          "0409-1098",
          "0409-1208"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "CISATRACURIUM BESYLATE"
        ],
        "rxcui": [
          "199211",
          "199212",
          "1730194"
        ],
        "spl_id": [
          "7b64e51a-1a55-4949-ac7c-b0a21cbd6ec9"
        ],
        "spl_set_id": [
          "67908e20-044d-454d-9c51-bf106e817bd0"
        ],
        "package_ndc": [
          "0409-1098-12",
          "0409-1098-02",
          "0409-1103-11",
          "0409-1103-01",
          "0409-1208-11",
          "0409-1208-01"
        ],
        "unii": [
          "80YS8O1MBS"
        ]
      },
      "update_date": "05/06/2026",
      "therapeutic_category": [
        "Analgesia/Addiction"
      ],
      "dosage_form": "Injection",
      "presentation": "Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01)",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "status": "To Be Discontinued"
    }
  ]
}